- Home
- RVNC vs VALN Comparison
RVNC vs VALN Comparison
Compare RVNC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- VALN
- Stock Information
- Founded
- RVNC 1999
- VALN 2012
- Country
- RVNC United States
- VALN France
- Employees
- RVNC N/A
- VALN N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVNC Health Care
- VALN Health Care
- Exchange
- RVNC Nasdaq
- VALN Nasdaq
- Market Cap
- RVNC 599.6M
- VALN 488.9M
- IPO Year
- RVNC 2014
- VALN 2021
- Fundamental
- Price
- RVNC $5.78
- VALN $5.48
- Analyst Decision
- RVNC Buy
- VALN Strong Buy
- Analyst Count
- RVNC 10
- VALN 2
- Target Price
- RVNC $10.86
- VALN $18.50
- AVG Volume (30 Days)
- RVNC 1.6M
- VALN 22.5K
- Earning Date
- RVNC 11-19-2024
- VALN 11-07-2024
- Dividend Yield
- RVNC N/A
- VALN N/A
- EPS Growth
- RVNC N/A
- VALN N/A
- EPS
- RVNC N/A
- VALN N/A
- Revenue
- RVNC $251,178,000.00
- VALN $176,817,979.00
- Revenue This Year
- RVNC $20.36
- VALN $24.30
- Revenue Next Year
- RVNC $31.66
- VALN $16.05
- P/E Ratio
- RVNC N/A
- VALN N/A
- Revenue Growth
- RVNC 40.23
- VALN N/A
- 52 Week Low
- RVNC $2.30
- VALN $5.40
- 52 Week High
- RVNC $9.75
- VALN $14.49
- Technical
- Relative Strength Index (RSI)
- RVNC 56.47
- VALN 36.84
- Support Level
- RVNC $5.67
- VALN $5.65
- Resistance Level
- RVNC $5.97
- VALN $5.93
- Average True Range (ATR)
- RVNC 0.19
- VALN 0.11
- MACD
- RVNC 0.06
- VALN -0.00
- Stochastic Oscillator
- RVNC 78.01
- VALN 1.35
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.